139 related articles for article (PubMed ID: 38420448)
1. A novel lysosome-related prognostic signature associated with prognosis and immune infiltration landscape in oral squamous cell carcinoma.
Liu JJ; Xu ZM; Liu Y; Guo XY; Zhang WB
Heliyon; 2024 Feb; 10(4):e26100. PubMed ID: 38420448
[TBL] [Abstract][Full Text] [Related]
2. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of a 4-lncRNA glycolysis-related signature in oral squamous cell carcinoma.
Wu L; Liu J; Li W
J Dent Sci; 2022 Apr; 17(2):991-1000. PubMed ID: 35756768
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a lysosome-related prognostic signature in breast cancer to predict immune infiltration and therapy response.
Su H; Chen Y; Lin F; Li W; Gu X; Zeng W; Liu D; Li M; Zhong S; Chen Q; Chen Q
Front Oncol; 2023; 13():1325452. PubMed ID: 38162504
[TBL] [Abstract][Full Text] [Related]
6. A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma.
Cao R; Wu Q; Li Q; Yao M; Zhou H
PeerJ; 2019; 7():e7360. PubMed ID: 31396442
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of a Hypoxia-Immune-Based Prognostic mRNA Signature for Oral Squamous Cell Carcinoma.
Lv S; Qian Z; Li J; Piao S; Li J
J Oncol; 2022; 2022():5286251. PubMed ID: 35178089
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma.
Hou C; Cai H; Zhu Y; Huang S; Song F; Hou J
Front Oncol; 2020; 10():558596. PubMed ID: 33178587
[TBL] [Abstract][Full Text] [Related]
9. Computational profiling and prognostic modeling based on lysosome-related genes in colorectal cancer.
Zhang L; Yang J; Deng Y; Deng W; Li L
Front Genet; 2023; 14():1203035. PubMed ID: 38075693
[No Abstract] [Full Text] [Related]
10. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
Wang L; Wang L; He P
Front Genet; 2022; 13():1064432. PubMed ID: 36568383
[No Abstract] [Full Text] [Related]
11. Molecular subtyping and prognostic risk characterization of head and neck squamous cell carcinoma based on lysosome-related genes.
Zhang A; Jin Y; Zou X; Zhang S
Medicine (Baltimore); 2023 Jul; 102(28):e34275. PubMed ID: 37443469
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtype identification and prognosis stratification based on lysosome-related genes in breast cancer.
Liu X; Sun K; Yang H; Zou D; Xia L; Lu K; Meng X; Li Y
Heliyon; 2024 Feb; 10(4):e25643. PubMed ID: 38420434
[TBL] [Abstract][Full Text] [Related]
14. A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis.
Yang Q; Cheng C; Zhu R; Guo F; Lai R; Liu X; Li M
Oral Oncol; 2022 Apr; 127():105771. PubMed ID: 35189585
[TBL] [Abstract][Full Text] [Related]
15. Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma.
Ai J; Tan Y; Liu B; Song Y; Wang Y; Xia X; Fu Q
Front Genet; 2023; 14():1113137. PubMed ID: 37636263
[No Abstract] [Full Text] [Related]
16. A novel T-cell proliferation-associated gene predicts prognosis and reveals immune infiltration in patients with oral squamous cell carcinoma.
Cui Y; Cheng Y; Huang W; Liu J; Zhang X; Bu M; Li X
Arch Oral Biol; 2023 Aug; 152():105719. PubMed ID: 37178584
[TBL] [Abstract][Full Text] [Related]
17. A novel lysosome-related gene signature coupled with gleason score for prognosis prediction in prostate cancer.
Huang Y; Yang F; Zhang W; Zhou Y; Duan D; Liu S; Li J; Zhao Y
Front Genet; 2023; 14():1135365. PubMed ID: 37065491
[No Abstract] [Full Text] [Related]
18. Comprehensive Characterization of Immune Landscape Based on Tumor Microenvironment for Oral Squamous Cell Carcinoma Prognosis.
Li QL; Mao J; Meng XY
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146599
[TBL] [Abstract][Full Text] [Related]
19. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
20. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Yang Z; Zi Q; Xu K; Wang C; Chi Q
Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
